DETAILSDescription:This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples. Type:AssayMax™ ELISA KitsSamples:SerumPlasmaCatalog Number:EA5201-7Species:HumanFormat:Competitive ELISASize:96 Well PlateRange:1.25 - 40 ug/mlResearch Area:Cardiovascular, Heart Disease, Cancer, MetabolismEntrez Gene:335Omim:107680UniProt:P02647Unigene:Hs.93194Synonyms:Apo A1, Apo-AI, ApoA-I, Apolipoprotein A1, ApoA1, Apolipoprotein A-I(1-242), ProapoA-I Note:For Research Use Only, Not To Be Used For Diagnostic PurposesProduct References:*Chen GL et al. (2010) High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease. Chinese Medical Journal 123:658-663 * Ling XB et al. (2010) Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. Proteomics. 2010 Dec;10(24):4415-30 *Vacirca D et al. (2011) Anti-ATP Synthase Autoantibodies from Patients with Alzheimer's Disease Reduce Extracellular HDL Level. Journal of Alzheimer's Disease 26(3):441-445*Charles-Schoeman C et al. (2012) Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 71(7):1157-1162 *Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1*Ghorbanian B et al. (2013) The Effects of Eight Weeks Interval Endurance Robe Training on Lymphocyte ABCA1 Protein Expression, Plasma Apolipoprotein A-I and HDL-cin Overweight and Obese Boy Adolescents. Int J Endocrinol Metab. 2013 Spring;11(2):76-81*Wang DX et al. (2013) The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease. Chin Med J 126 (19): 3656-3661*Martos-Moreno GA et al. (2014) Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children.Int J Pediatr Endocrinol. 2014(1):9. doi: 10.1186*Sharma S et al. (2014) Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers. Sci Rep. 4:7140. doi: 10.1038/srep07140*Cubedo J et al. (2015) A novel truncated form of Apolipoprotein A-I transported by dense LDL is increased in diabetic patients. J Lipid Res. 2015 Jul 13* Ray S et al. (2015) Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity. J Proteomics. 127:103-113* Sharma S (2015) Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics. 15(2-3):394-407*Taylor JK (2015) Paraoxonase Responses to Exercise and Niacin Therapy in Men with Metabolic Syndrome. Redox Rep. 2015 Jan;20(1):42-8*Wu T et al. (2015) The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols. J Pharmacol Sci. 127(3):251-9. doi: 10.1016/j.jphs.2014.12.002. Epub 2014 Dec 15* El-Gendy FM et al. (2018) Diagnostic value of apolipoprotein A1 in neonatal sepsis. Menoufia Medical Journal. 31(3):1011-1017* Tortorici MA et al. (2019) Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function. Clinical Pharmacology in Drug Development. 8(5):628-636